Navigation Links
Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
Date:9/10/2009

ABBOTT PARK, Ill. and MENLO PARK, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today a definitive agreement to acquire the outstanding equity of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves. The acquisition provides Abbott with a presence in the growing area of non-surgical treatment for structural heart disease, in which physicians use catheter-based devices to repair or replace basic structural components of the heart such as mitral and aortic valves. The agreement includes an upfront payment of $320 million in cash, plus an additional payment upon completion of certain regulatory milestones, for a total of up to $410 million.

"The acquisition of Evalve will provide Abbott with leading technology in the emerging field of minimally invasive heart valve repair and further broadens Abbott's medical devices portfolio," said John M. Capek, Ph.D., executive vice president, Medical Devices, Abbott. "Evalve is on the cutting edge with its non-surgical approach to treating structural heart disease. With this breakthrough mitral valve repair technology, physicians will be able to offer their patients a minimally invasive alternative to open heart surgery -- not unlike the opportunity that stents provided more than two decades ago for the treatment of coronary artery disease."

Mitral regurgitation, a condition that prevents the mitral valve from closing completely, is the most common type of heart valve insufficiency in Europe and the United States, and affects millions of people worldwide. Traditionally, mitral regurgitation is treated through open heart surgery. However, only about 20 percent of the 600,000 patients diagnosed in the U.S. and Europe each year undergo surger
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
2. Abbott HIV Test Demonstrates Earlier Disease Detection
3. Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
4. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
5. Abbott Named One of the Top 10 Companies for Scientists
6. HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
7. Abbott to Present at Barclays Global Healthcare Conference
8. Abbott Employee Giving Sets New Records for Employee Participation and Total Donations
9. Abbott Announces 11 Percent Increase in Quarterly Dividend
10. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
11. Abbott Announces Earnings Guidance for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Verenium Corporation (Nasdaq: ... focused on the development and commercialization of high-performance enzymes, ... Chief Financial Officer, will present at two upcoming conferences. ... Black will present at the Second Annual Marcum LLP ... Grand Hyatt Hotel in New York City.  The presentation ...
(Date:5/23/2013)... 2013 Pusan National University Yangsan Hospital, ... and contract research company focused on research and ... today a publication reporting the induction of functional ... and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). ... the May 15 th , 2013 issue of ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... of genetics-based ancestry tracing for people of African ... myDNAmix Admixture product offering. For people of all ... genetic make-up from five distinct populations: Indigenous Americas ... Europe and India Subcontinent. , Originally ...
(Date:5/23/2013)... PA (PRWEB) May 23, 2013 Bed ... that the university had already confirmed it. Meanwhile, My Cleaning ... help bed bug victims fight the pests without using harmful ... posted on May 15, 2013, the affected building was actually ... it being infested was said made on May 13 and ...
Breaking Biology Technology:Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... somehow survived where other traditional marketing tools and old ... must face harsher realities once again, all to ensure ... Web sites are simply doomed. While billions of Web ... clash into the billions of surfing customers and simply ...
... Ted Kanavas, R-Brookfield, called on the Legislature and the ... Development Fund. , ,The fund would use existing information ... Administration and segregate a portion of the funds for ... would not flow into this fund. , ,This fund ...
... Corporation and First Data Corporation jointly ... provides for the purchase of substantially all of the ... approximately $610 million in cash. As the majority shareholder ... million and NYCE will become a Metavante subsidiary. , ...
Cached Biology Technology:The mysteries and the future of Web sites 2The mysteries and the future of Web sites 3The mysteries and the future of Web sites 4Metavante and First Data to buy PIN-debit company NYCE 2
(Date:5/23/2013)... medics have succeeded in treating cerebral palsy with autologous ... damage, a 2.5 year old boy had been in ... survival. Just two months after treatment with the cord ... the following months, the child learned to speak simple ... from a Korean study, dispel the long-held doubts about ...
(Date:5/23/2013)... Frontiers, one of the world,s largest and fastest ... new journal, Frontiers in Bioengineering and Biotechnology ... all specialties, Frontiers in Bioengineering and Biotechnology ... diverse and emerging bioengineering and biotechnology research to ... in Bioengineering and Biotechnology will provide an ...
(Date:5/23/2013)... In an age when microbial pathogens are growing ... down infection, a team of Wisconsin scientists has synthesized ... the bacteria that cause staph infections. , Writing online ... , a group led by University of Wisconsin-Madison chemistry ... the "quorum sensing" behavior of Staphylococcus aureus , ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2University of Wisconsin chemists find new compounds to curb staph infection 2
... It is estimated that 38 million people worldwide are ... are added each year. For scientists to design treatment ... essential to learn more about how the virus mutates ... by University of Victoria biomedical engineer Stephanie Willerth has ...
... III efficacy data from the GeparQuinto study, a head-to-head ... chemotherapy for patients with early breast cancer, at the ... Dec. 8-12. "We had a primary goal ... trastuzumab, with the new combination of chemotherapy and lapatinib," ...
... Alexandria, VA America has made great strides in recent ... to other, low or non-carbon energy sources. Meanwhile, carbon emissions ... looks at this disparity and asks the difficult questions about ... is imported from "cleaner" countries and the emissions are produced ...
Cached Biology News:UVic biomedical engineer 'outsmarts' HIV 2Phase III study compared neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer 2
... system for detection of very low level ... Equipped with an extreme sensitive camera to ... plants in tumor research, infectious disease research, ... NightOWL is the only imager with a ...
... (Complex Object Parametric Analyzer and Sorter) large ... the advantages of flow cytometry to applications ... for automated analysis and sorting. Our ... as traditional flow cytometers, but are designed ...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
...
Biology Products: